American National Bank & Trust’s Inovio Pharmaceuticals INO Stock Holding History

American National Bank & Trust’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-200	Closed	-$407	–	668
2025 Q2	$407	Hold	200	–	–	﹤0.01%	636
2025 Q1	$326	Hold	200	–	–	﹤0.01%	585
2024 Q4	$366	Hold	200	–	–	﹤0.01%	501
2024 Q3	$1.16K	Hold	200	–	–	﹤0.01%	452
2024 Q2	$1.62K	Hold	200	–	–	﹤0.01%	519
2024 Q1	$2.78K	Buy	+200	New	+$1.73K	﹤0.01%	451

Other funds holding INO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American National Bank & Trust's INO Position: Q3 2025 in Review

American National Bank & Trust sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 200 shares — an estimated $407 sold.

American National Bank & Trust first reported a position in INO in Q1 2024 and held it in 6 quarters. The position peaked at $2.78K in Q1 2024. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

American National Bank & Trust reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
American National Bank & Trust sold 200 Inovio Pharmaceuticals shares in Q3 2025, an estimated $407.
American National Bank & Trust first reported a position in Inovio Pharmaceuticals in Q1 2024 and held it in 6 quarters.
American National Bank & Trust's Inovio Pharmaceuticals position peaked at $2.78K in Q1 2024.
99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on American National Bank & Trust's 13F filing for Q3 2025, filed 21 Oct 2025.